サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788293

プランタブル・パッケージングの世界市場

Plantable Packaging

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.69円
プランタブル・パッケージングの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プランタブル・パッケージングの世界市場は2030年までに3億1,610万米ドルに達する見込み

2024年に1億5,640万米ドルと推定されるプランタブル・パッケージングの世界市場は、2024年から2030年にかけてCAGR 12.4%で成長し、2030年には3億1,610万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるバガスは、CAGR 14.7％を記録し、分析期間終了時には9,640万米ドルに達する見込みです。デンプンベースセグメントの成長率は、分析期間でCAGR 10.4％と推定されます。

米国市場は4,110万米ドルと推定される一方、中国はCAGR 11.6％で成長すると予測される

米国のプランタブル・パッケージング市場は、2024年に4,110万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに4,890万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.8％と10.4％と予測されています。欧州では、ドイツがCAGR約8.8％で成長すると予測されています。

世界の植物由来API市場- 主要動向と促進要因のまとめ

植物由来API（医薬品有効成分）市場は、天然医薬品に対する消費者の需要の高まり、医薬品研究開発投資の増加、植物抽出・生合成技術の進歩などを背景に、急速に拡大しています。植物由来APIは、薬草、アルカロイド、フラボノイド、配糖体、テルペノイドなどの植物由来のもので、医薬品、栄養補助食品、バイオテクノロジー用途で利用価値が高いです。

市場を形成する最も重要な動向のひとつは、合成医薬品よりも植物由来の医薬品を好む傾向が高まっていることです。植物由来の生物活性化合物とその治療効果に対する認識が高まるにつれ、製薬会社は腫瘍学、心血管疾患、疼痛管理、神経変性疾患向けの植物性医薬品製剤に投資しています。さらに、植物由来の原薬は、アーユルヴェーダ、中国伝統医学（TCM）、ハーブサプリメントなどの伝統医学システムで広く使用されており、世界市場の成長に寄与しています。

もう一つの主な推進力は、持続可能で環境に優しい医薬品開発へのシフトです。従来のAPI合成は、複雑な化学反応、刺激の強い溶媒、エネルギー集約的なプロセスを伴うことが多く、二酸化炭素排出量の増加や環境への懸念につながっています。対照的に、植物由来のAPIは、生態系への影響が少なく、再生可能な原料を使用し、化学廃棄物を最小限に抑えた、より環境に優しい代替品を提供します。バイオ医薬品抽出、植物細胞培養技術、酵素生合成の採用は、植物由来の医薬品製造の効率をさらに高めています。

さらに、規制当局の承認と植物由来医薬品の臨床検証の増加が、市場の拡大に拍車をかけています。米国FDA、欧州医薬品庁（EMA）、WHOなどの規制機関は、植物由来原薬の治療効果を認めており、より多くの植物由来医薬品が商業用として承認されるようになっています。植物由来の製剤に関する特許出願が増加する中、製薬会社は慢性疾患、免疫療法、抗炎症治療に対する新規植物由来化合物の研究を加速させています。

植物由来原薬は医薬品業界をどのように変革しているのか？

製薬業界では、循環器系薬剤、鎮痛剤、抗がん剤治療、中枢神経系（CNS）治療などの主な用途で、植物由来原薬へのシフトが進んでいます。天然で生物学的利用能が高く、リスクの低い製剤への需要が、処方薬と一般用医薬品（OTC）の両方における植物由来原薬の採用を促進しています。

最も顕著な用途のひとつはがん治療で、パクリタキセル（Taxus brevifolia由来）やビンブラスチン／ビンクリスチン（Catharanthus roseus由来）などの植物由来原薬が化学療法に広く使用されています。これらの植物由来の抗がん剤は、高い効力、低毒性、患者耐性の改善を実証しており、現代のがん治療にとって極めて重要なものとなっています。

ジゴキシン（ジギタリス・プルプレア由来）やレセルピン（ラウロルフィア・セルペンティナ由来）などの植物由来原薬が、心不全、高血圧、不整脈の治療に使用されています。心血管系疾患の世界の有病率の増加は、最小限の副作用で効果的な疾患管理を提供する天然心血管系薬剤の需要を押し上げています。

疼痛管理や抗炎症治療では、植物由来のアルカロイドやフラボノイドが広く使用されています。モルヒネ（Papaver somniferum由来）とアスピリン（Salix alba、ヤナギの樹皮由来）は、植物由来の鎮痛剤のよく確立された例であり、疼痛緩和と慢性疾患管理における植物化学原薬の可能性を強調しています。さらに、クルクミン（クルクマ・ロンガ由来）とカンナビジオール（CBD、カンナビス・サティバ由来）は、抗炎症、神経保護、疼痛緩和治療において人気を集めています。

さらに、メンタルヘルスと神経医薬品の分野では、シロシビン（サイロシベ茸由来）、カンナビジオール（CBD）、伝統的な薬用植物由来のアルカロイドなど、植物由来の精神活性原薬が増加しています。植物由来の向精神薬、抗不安薬、抗うつ薬の研究により、精神医学や認知機能強化療法における植物由来API開発の新たな道が開かれつつあります。

植物由来APIの成長を牽引するイノベーションとは？

植物由来API産業は急速に進化しており、バイオテクノロジー、合成生物学、グリーンケミストリーが、APIの抽出、精製、スケーラビリティの向上において重要な役割を果たしています。

最も重要なイノベーションの一つは、医薬品グレードの原薬を生産するための植物細胞培養とバイオファーミングの利用です。従来の培養や抽出とは異なり、植物細胞培養技術は、生物活性化合物の制御、無菌、高収率生産を可能にします。この方法により、季節変動、農薬への曝露、資源集約的な農業が排除され、一貫した原薬の品質とサプライチェーンの安定性が確保されます。

もうひとつのブレークスルーは、植物ベースの医薬品合成のための合成生物学と代謝工学です。植物の代謝経路を改変し、微生物発酵を利用することで、研究者はバイオリアクターで高価値の植物由来原薬を生産し、成長の遅い薬用植物への依存を減らすことができます。これは、希少種や絶滅危惧種の薬用植物にとって特に有益であり、タキソール、アトロピン、アルテミシニンなどの需要の高い原薬を持続的に生産することができます。

さらに、超臨界CO2抽出とグリーン溶剤は、従来の溶剤ベースの抽出法に取って代わり、原薬の純度、安定性、環境の持続可能性を向上させています。この技術は、有毒化学物質を使用せずに植物由来の必須分子を高効率で抽出できるため、医薬品や栄養補助食品の用途に最適です。

AI主導の創薬と計算植物化学の台頭は、植物由来の新規原薬の同定をさらに加速させています。AIアルゴリズムは、膨大な植物データベースを分析し、薬理学的特性を予測し、抽出技術を最適化することで、植物由来医薬品の研究開発（R&D）のタイムラインを大幅に短縮することができます。

植物由来API市場の成長を促進する主な要因は何か？

植物由来API市場の成長は、天然医薬品に対する消費者の嗜好の高まり、植物医薬品研究に対する製薬企業の投資の増加、植物由来治療薬に対する規制当局の支援など、いくつかの要因によってもたらされます。

主な促進要因の1つは、特に自然でホリスティックなヘルスケアアプローチが好まれる地域において、植物由来医薬品やハーブ医薬品への世界のシフトです。アーユルヴェーダ、中国伝統医学（TCM）、ハーブベースの医薬品の採用が増加していることが、標準化され、臨床的に検証された植物由来原薬の需要を促進しています。

もう一つの重要な要因は、がん、心血管疾患、自己免疫疾患などの慢性疾患の有病率の増加です。製薬企業がより安全で効果的な製剤を求める中、有効性が証明され毒性プロファイルが低い植物由来原薬は、合成薬に代わる魅力的な選択肢になりつつあります。

持続可能で環境に優しい医薬品製造に対する需要の高まりも、市場の成長に影響を与えています。従来の化学的な原薬製造は、高レベルの産業廃棄物や温室効果ガスの排出を発生させるため、規制機関や製薬会社は、植物由来の医薬品製造のためのグリーン抽出技術や環境に優しい生合成アプローチへの投資を促しています。

さらに、薬用大麻と精神活性植物化合物の合法化と商業化は、神経学、精神医学、疼痛管理における新たな機会を開いています。CBDベースの医薬品、シロシビン補助療法、植物由来の精神科治療を合法化している国々は、市場の拡大と植物ベースの医薬品研究開発への投資を加速させています。

植物由来の医薬品研究、バイオテクノロジーの革新、規制当局の承認が拡大し続ける中、植物由来API市場は大きく成長する態勢を整えています。持続可能な生産方法、AIを活用した創薬、高純度の植物由来API製剤に投資する企業は、自然医療と植物由来医薬品の進歩の次の時代をリードする立場にあると思われます。

セグメント

素材（バガス、でんぷんベース、バイオプラスチック、セルロース、海藻、その他）、タイプ（軟包装、硬包装）、用途（飲食品、化粧品、医薬品、工業用）

調査対象企業の例

  • Biocup（eCup）
  • Bloomin
  • Botanical PaperWorks
  • Custom Earth Promos
  • Earthly Goods
  • Earthodic
  • EcoEnclose
  • Ecovative Design
  • Footprint
  • Golden Idea
  • Green Field Paper Company
  • JBM Packaging
  • Mondi Group
  • PaperFoam
  • Plantable Seed Paper
  • PulpWorks, Inc.
  • Ranpak
  • Seed Paper India
  • The Mend Packaging
  • UK Seed Paper

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32583

Global Plantable Packaging Market to Reach US$316.1 Million by 2030

The global market for Plantable Packaging estimated at US$156.4 Million in the year 2024, is expected to reach US$316.1 Million by 2030, growing at a CAGR of 12.4% over the analysis period 2024-2030. Bagasse, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$96.4 Million by the end of the analysis period. Growth in the Starch-based segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.1 Million While China is Forecast to Grow at 11.6% CAGR

The Plantable Packaging market in the U.S. is estimated at US$41.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$48.9 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.8% and 10.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Global Plant-Based API Market - Key Trends & Drivers Summarized

The plant-based API (Active Pharmaceutical Ingredient) market is expanding rapidly, driven by growing consumer demand for natural medicines, increasing pharmaceutical R&D investments, and advancements in plant extraction and biosynthesis technologies. Plant-based APIs are derived from botanical sources such as medicinal herbs, alkaloids, flavonoids, glycosides, and terpenoids, making them valuable in pharmaceutical, nutraceutical, and biotechnology applications.

One of the most significant trends shaping the market is the rising preference for plant-based pharmaceuticals over synthetic drugs. With increasing awareness of plant-derived bioactive compounds and their therapeutic benefits, pharmaceutical companies are investing in botanical drug formulations for oncology, cardiovascular diseases, pain management, and neurodegenerative disorders. Additionally, plant-based APIs are widely used in traditional medicine systems, such as Ayurveda, Traditional Chinese Medicine (TCM), and herbal supplements, contributing to global market growth.

Another key driver is the shift toward sustainable and eco-friendly drug development. Traditional API synthesis often involves complex chemical reactions, harsh solvents, and energy-intensive processes, leading to high carbon emissions and environmental concerns. In contrast, plant-based APIs offer greener alternatives, with lower ecological impact, renewable sourcing, and minimal chemical waste. The adoption of biopharmaceutical extraction, plant cell culture technology, and enzymatic biosynthesis is further enhancing the efficiency of plant-based drug manufacturing.

Furthermore, regulatory approvals and increasing clinical validation of plant-based drugs are fueling market expansion. Regulatory agencies such as the U.S. FDA, European Medicines Agency (EMA), and WHO are recognizing the therapeutic efficacy of botanical APIs, leading to more plant-derived drugs being approved for commercial use. With increasing patent filings for plant-based formulations, pharmaceutical companies are accelerating research into novel plant-derived compounds for chronic diseases, immunotherapy, and anti-inflammatory treatments.

How Are Plant-Based APIs Transforming the Pharmaceutical Industry?

The pharmaceutical industry is witnessing a growing shift toward plant-based APIs, with major applications in cardiovascular drugs, pain relievers, anti-cancer therapies, and central nervous system (CNS) treatments. The demand for natural, bioavailable, and lower-risk drug formulations is driving the adoption of botanical APIs in both prescription and over-the-counter (OTC) medications.

One of the most prominent applications is oncology, where plant-derived APIs such as paclitaxel (from Taxus brevifolia) and vinblastine/vincristine (from Catharanthus roseus) are widely used in chemotherapy treatments. These plant-based anticancer drugs have demonstrated high potency, lower toxicity, and improved patient tolerance, making them crucial for modern cancer therapies.

Another rapidly expanding segment is cardiovascular medicine, where plant-based APIs such as digoxin (from Digitalis purpurea) and reserpine (from Rauwolfia serpentina) are used to treat heart failure, hypertension, and arrhythmias. The increasing prevalence of cardiovascular diseases worldwide is boosting demand for natural cardiovascular drugs that offer effective disease management with minimal side effects.

In pain management and anti-inflammatory treatments, plant-based alkaloids and flavonoids are widely used. Morphine (from Papaver somniferum) and aspirin (derived from Salix alba, or willow bark) are well-established examples of plant-based analgesics, highlighting the potential of phytochemical APIs in pain relief and chronic disease management. Additionally, curcumin (from Curcuma longa) and cannabidiol (CBD, from Cannabis sativa) are gaining popularity in anti-inflammatory, neuroprotective, and pain-relief therapies.

Furthermore, the mental health and neuropharmaceutical sector is experiencing a rise in plant-based psychoactive APIs, such as psilocybin (from Psilocybe mushrooms), cannabidiol (CBD), and alkaloids from traditional medicinal plants. Research on plant-derived nootropics, anxiolytics, and antidepressants is opening new avenues for plant-based API development in psychiatric medicine and cognitive enhancement therapies.

What Innovations Are Driving the Growth of Plant-Based APIs?

The plant-based API industry is evolving rapidly, with biotechnology, synthetic biology, and green chemistry playing crucial roles in enhancing API extraction, purification, and scalability.

One of the most significant innovations is the use of plant cell culture and biopharming to produce pharmaceutical-grade APIs. Unlike traditional cultivation and extraction, plant cell culture technology allows controlled, sterile, and high-yield production of bioactive compounds. This method eliminates seasonal variability, pesticide exposure, and resource-intensive farming, ensuring consistent API quality and supply chain stability.

Another breakthrough is synthetic biology and metabolic engineering for plant-based drug synthesis. By modifying plant metabolic pathways and using microbial fermentation, researchers can produce high-value plant-based APIs in bioreactors, reducing dependence on slow-growing medicinal plants. This is particularly beneficial for rare or endangered medicinal plant species, allowing sustainable production of high-demand APIs such as taxol, atropine, and artemisinin.

Additionally, supercritical CO2 extraction and green solvents are replacing traditional solvent-based extraction methods, improving API purity, stability, and environmental sustainability. This technology enables high-efficiency extraction of essential plant-derived molecules without the use of toxic chemicals, making it ideal for pharmaceutical and nutraceutical applications.

The rise of AI-driven drug discovery and computational phytochemistry is further accelerating the identification of new plant-based APIs. AI algorithms can analyze vast botanical databases, predict pharmacological properties, and optimize extraction techniques, significantly reducing research and development (R&D) timelines for plant-derived drugs.

What Are the Key Factors Driving the Growth of the Plant-Based API Market?

The growth in the plant-based API market is driven by several factors, including rising consumer preference for natural medicines, increasing pharmaceutical investment in botanical drug research, and regulatory support for plant-derived therapeutics.

One of the primary drivers is the global shift toward plant-based and herbal medicines, particularly in regions where natural, holistic healthcare approaches are preferred. The increasing adoption of Ayurvedic, Traditional Chinese Medicine (TCM), and herbal-based pharmaceuticals is fueling demand for standardized, clinically validated plant-based APIs.

Another key factor is the growing prevalence of chronic diseases, including cancer, cardiovascular disorders, and autoimmune conditions. As pharmaceutical companies seek safer, more effective drug formulations, plant-derived APIs with proven efficacy and lower toxicity profiles are becoming attractive alternatives to synthetic drugs.

The rising demand for sustainable and environmentally friendly pharmaceutical production is also influencing market growth. Traditional chemical API manufacturing generates high levels of industrial waste and greenhouse gas emissions, prompting regulatory agencies and pharmaceutical companies to invest in green extraction technologies and eco-friendly biosynthetic approaches for plant-based drug production.

Additionally, the legalization and commercialization of medicinal cannabis and psychoactive plant compounds are opening new opportunities in neurology, psychiatry, and pain management. Countries legalizing CBD-based drugs, psilocybin-assisted therapies, and plant-derived psychiatric treatments are accelerating market expansion and investment in plant-based drug R&D.

As plant-based pharmaceutical research, biotechnology innovations, and regulatory approvals continue to expand, the plant-based API market is poised for significant growth. Companies that invest in sustainable production methods, AI-powered drug discovery, and high-purity botanical API formulations will be well-positioned to lead the next era of natural medicine and plant-based pharmaceutical advancements.

SCOPE OF STUDY:

The report analyzes the Plantable Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed, Others); Type (Flexible Packaging, Rigid Packaging); Application (Food & Beverages, Cosmetics, Pharmaceuticals, Industrial)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Biocup (eCup)
  • Bloomin
  • Botanical PaperWorks
  • Custom Earth Promos
  • Earthly Goods
  • Earthodic
  • EcoEnclose
  • Ecovative Design
  • Footprint
  • Golden Idea
  • Green Field Paper Company
  • JBM Packaging
  • Mondi Group
  • PaperFoam
  • Plantable Seed Paper
  • PulpWorks, Inc.
  • Ranpak
  • Seed Paper India
  • The Mend Packaging
  • UK Seed Paper

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Plantable Packaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Consumer Preference for Sustainable and Zero-Waste Products Spurs Demand for Plantable Packaging
    • Growing Anti-Plastic Legislation and Extended Producer Responsibility (EPR) Policies Accelerate Shift to Biodegradable, Plantable Solutions
    • Expansion of Eco-Friendly Branding and Corporate Sustainability Goals Strengthens Business Case for Plantable Packaging
    • Innovation in Seed-Embedded Paper and Biopolymer Materials Enables Functional, Compostable Packaging Formats
    • Boom in E-Commerce and D2C Brands Fuels Adoption of Plantable Packaging for Eco-Conscious Unboxing Experiences
    • Increased Consumer Awareness of Circular Economy Principles Supports Demand for Regenerative Packaging Models
    • Retailers and Food Brands Leverage Plantable Packaging to Strengthen ESG Commitments and Consumer Loyalty
    • Advancements in Printable and Customizable Seed Paper Materials Drive Aesthetic and Marketing Appeal
    • Use of Native, Non-Invasive Seed Types Enhances Regional Adaptability and Environmental Impact
    • Growth of Organic and Natural Product Categories Aligns with Use of Plantable, Plastic-Free Packaging
    • Sustainability Certifications and Green Labels Boost Market Credibility and Retail Shelf Presence
    • Rising Popularity of Gifting and Subscription Boxes Drives Demand for Interactive, Plant-Growth-Enabled Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Plantable Packaging Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Plantable Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Plantable Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bagasse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Bagasse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Starch-based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Starch-based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Bioplastics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Bioplastics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cellulose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cellulose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Seaweed by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Seaweed by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Food & Beverages by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Food & Beverages by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Flexible Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Flexible Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Rigid Packaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Rigid Packaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 28: USA Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • CANADA
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • JAPAN
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • CHINA
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 46: China Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • EUROPE
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Plantable Packaging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Plantable Packaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • FRANCE
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 60: France Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • GERMANY
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • ITALY
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • UNITED KINGDOM
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 78: UK Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Plantable Packaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Plantable Packaging by Material - Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Plantable Packaging by Material - Percentage Breakdown of Value Sales for Bagasse, Starch-based, Bioplastics, Cellulose, Seaweed and Others for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Plantable Packaging by Application - Cosmetics, Pharmaceuticals, Industrial and Food & Beverages - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Plantable Packaging by Application - Percentage Breakdown of Value Sales for Cosmetics, Pharmaceuticals, Industrial and Food & Beverages for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Plantable Packaging by Type - Flexible Packaging and Rigid Packaging - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Plantable Packaging by Type - Percentage Breakdown of Value Sales for Flexible Packaging and Rigid Packaging for the Years 2025 & 2030

IV. COMPETITION